增强的口腔与侧侧淋巴结T细胞反应,与抗PD1在头癌中的疗效相匹配

Michihisa Kono1, Shin Saito2, Masahiro Rokugo2

  • 1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States; Department of Otolaryngology - Head and Neck Surgery, Asahikawa Medical University, Asahikawa, Japan.

Oral oncology
|April 10, 2024
PubMed
概括

头部和部状细胞癌 (HNSCC) 模型显示出不同的免疫反应. 与皮下模型相比,正位口腔瘤引起更强的T细胞激活和抗PD1治疗反应,影响临床前HNSCC研究.